ARTES Biotechnology
ARTES Biotechnology is a global and reliable technology provider for the production of recombinant proteins, specializing in microbial cell line and process development for vaccines, biopharmaceuticals, biosimilars, and enzymes. They offer transfer processes for enzymes, vaccines, and biosimilars, and have a broad portfolio of proprietary technologies including VLP vaccine development. The company operates worldwide from its facilities in Langenfeld, Germany, and has a history of over 20 years of successful partnerships with human and animal health companies, enzyme manufacturers, and the cosmetic, diagnostic, and nutrition industries.
Industries
Nr. of Employees
small (1-50)
ARTES Biotechnology
Langenfeld, Rheinland-Pfalz, Germany, Europe
Products
Research reagents: recombinant antigens, enzymes and functional proteins
Catalog of recombinant research reagents produced in microbial expression systems for use in academic and industrial laboratories.
Recombinant Human Serum Albumin (rHSA) — research grade
Small‑batch recombinant human serum albumin produced in yeast for laboratories and industry needing high‑quality recombinant albumin for research applications.
Research reagents: recombinant antigens, enzymes and functional proteins
Catalog of recombinant research reagents produced in microbial expression systems for use in academic and industrial laboratories.
Recombinant Human Serum Albumin (rHSA) — research grade
Small‑batch recombinant human serum albumin produced in yeast for laboratories and industry needing high‑quality recombinant albumin for research applications.
Services
CDMO services: microbial cell line and process development
Contract development services for microbial production cell lines and process development for recombinant proteins and vaccines, including feasibility studies, expression optimization, cell bank generation, and preliminary fermentation.
CDMO services: fermentation and downstream process development
Upstream and downstream process development focusing on reproducibility, cost reduction and transferability to cGMP manufacturing; includes in‑process controls and assay development.
Manufacturing of non‑GMP and cGMP material
Manufacturing services for test and preclinical material at non‑GMP and cGMP standards, including upscaling, quality control, method transfer and project management.
VLP vaccine development and antigen presentation services
Design and development of VLP‑based vaccine candidates and antigen display strategies, including expression in yeast hosts, VLP purification process development and immunogenicity testing in animal models.
Technology transfer and licensing services
Out‑licensing and transfer of processes, cell lines and documentation with training and on‑site support; negotiation of commercial licensing terms and technical implementation support.
CDMO services: microbial cell line and process development
Contract development services for microbial production cell lines and process development for recombinant proteins and vaccines, including feasibility studies, expression optimization, cell bank generation, and preliminary fermentation.
CDMO services: fermentation and downstream process development
Upstream and downstream process development focusing on reproducibility, cost reduction and transferability to cGMP manufacturing; includes in‑process controls and assay development.
Manufacturing of non‑GMP and cGMP material
Manufacturing services for test and preclinical material at non‑GMP and cGMP standards, including upscaling, quality control, method transfer and project management.
VLP vaccine development and antigen presentation services
Design and development of VLP‑based vaccine candidates and antigen display strategies, including expression in yeast hosts, VLP purification process development and immunogenicity testing in animal models.
Technology transfer and licensing services
Out‑licensing and transfer of processes, cell lines and documentation with training and on‑site support; negotiation of commercial licensing terms and technical implementation support.
Expertise Areas
- Microbial cell line development
- Fermentation and downstream bioprocess development
- Virus‑like particle (VLP) vaccine development
- Technology transfer and licensing of bioprocesses
Key Technologies
- Hansenula polymorpha yeast expression
- Pichia and Saccharomyces yeast expression
- E. coli expression systems
- Virus‑like particle (VLP) platforms for antigen display